| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |